On June 3, 2009, the House Judiciary Courts and Competition Policy Subcommittee will hold a hearing, “Pay to Delay: Are Patent Settlements That Delay Generic Drug Market Entry Anticompetitive?”, sure to interest all prescription drug manufacturers. No witness list is posted yet.